These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2970916)

  • 1. Insulin antibodies in diabetic children before treatment: a marker for islet B-cell destruction?
    De Beaufort CE; Binder C; Bruining GJ; Den Boer NC; Van Strik R
    Diabet Med; 1988; 5(5):441-3. PubMed ID: 2970916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.
    Wallensteen M; Dahlquist G; Persson B; Landin-Olsson M; Lernmark A; Sundkvist G; Thalme B
    Diabetologia; 1988 Sep; 31(9):664-9. PubMed ID: 3069534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.
    Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK
    Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children.
    Ludvigsson J; Binder C; Mandrup-Poulsen T
    Diabetologia; 1988 Sep; 31(9):647-51. PubMed ID: 3069532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
    Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
    Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of insulin antibodies in newly-diagnosed type 1 diabetic children after "acid-stripping" of sera.
    Rayner ML; Harrison LC; Campbell IL; Heyma P; Cook JJ
    Diabetes Res; 1987 Sep; 6(1):1-4. PubMed ID: 3319350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on urinary C-peptide excretion in normal children and children with insulin-dependent diabetes mellitus].
    Kusayanagi T
    Nihon Ika Daigaku Zasshi; 1989 Apr; 56(2):103-22. PubMed ID: 2659621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes.
    Knip M; Ilonen J; Mustonen A; Akerblom HK
    Diabetologia; 1986 Jun; 29(6):347-51. PubMed ID: 3527834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children.
    Lernmark A; Hägglöf B; Freedman Z; Irvine J; Ludvigsson J; Holmgren G
    Diabetologia; 1981 Apr; 20(4):471-4. PubMed ID: 7016642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
    Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of insulin antibodies, metabolic control and B-cell function in newly diagnosed insulin dependent diabetic children treated with monocomponent human insulin or monocomponent porcine insulin.
    Marshall MO; Heding LG; Villumsen J; Akerblom HK; Baevre H; Dahlquist G; Kjaergaard JJ; Knip M; Lindgren F; Ludvigsson J
    Diabetes Res; 1988 Dec; 9(4):169-75. PubMed ID: 3073903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.
    Ludvigsson J
    Diabetologia; 1984 Feb; 26(2):138-41. PubMed ID: 6370760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a short prednisone regime at clinical onset of type 1 diabetes.
    Goday A; Pujol-Borrell R; Fernandez J; Casamitjana R; Rios M; Vilardell E; Gomis R
    Diabetes Res Clin Pract; 1993 Apr; 20(1):39-46. PubMed ID: 8344127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children.
    Landin-Olsson M; Palmer JP; Lernmark A; Blom L; Sundkvist G; Nyström L; Dahlquist G
    Diabetologia; 1992 Nov; 35(11):1068-73. PubMed ID: 1473617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes--a poor predictor of clinical course and antibody response to exogenous insulin.
    Karjalainen J; Knip M; Mustonen A; Akerblom HK
    Diabetologia; 1988 Mar; 31(3):129-33. PubMed ID: 3286339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy.
    Arslanian SA; Becker DJ; Rabin B; Atchison R; Eberhardt M; Cavender D; Dorman J; Drash AL
    Diabetes; 1985 Sep; 34(9):926-30. PubMed ID: 3896901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.